Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer

Lung Cancer

Volumn 21, Issue 1, 1998, Pages 1-6

  Roth, Jack A ^a   Atkinson, E Neely ^a   Fossella, Frank ^a   Komaki, Ritsuko ^a   Ryan, M Bernadette ^b   Putnam Jr , J B ^a   Lee, Jin Soo ^a   Dhingra, Hari ^c   De Caro, Louis ^d   Chasen, Marvin ^a   Hong, Waun Ki ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Department of Orthopaedic Surgery Bassett Health Care Network   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CLINIQUE DE GENOLIER   (Switzerland)

Author keywords

Cisplatin; Induction chemotherapy; Lung cancer; Randomized trial

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032429392     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(98)00046-4     Document Type: Article

References (17)

1. Burkes R.L., Ginsberg R.J., Shepherd F.A., Blackstein M.E., Goldberg M.E., Waters P.F., Patterson G.A., Tood T., Pearson F.G., Cooper J.D., Jones D., Lockwood G. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto phase II trial. J Clin Oncol. 10(4):1992;580-586.
2. Cox DR, Hinkley DV. Theoretical statistics. New York: Chapman and Hall, 1974.
3. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
4. Eagan R.T., Ruud C., Lee R.E., Pairolero P.C., Gail M.H. Pilot study of induction therapy with cyclophosamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small-cell lung cancer. Cancer Treat Rep. 71:1987;895-900.
5. Faber L.P., Kittle C.F., Warren W.H., Bonomi P.D., Taylor S.G.I., Reddy S., Lee M.-S. Preoperative chemotherapy and radiation for stage III non-small cell lung cancer. Ann Thorac Surg. 47:1989;669-677.
6. Lung Cancer Study Group, Holmes E.C., Gail M. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol. 4:1986;710-715.
7. Lad T., Rubinstein L., Sadeghi A. The benefit of adjuvant treatment for resected locally advanced non-small cell lung cancer. J Clin Oncol. 6:1988;9-17.
8. Martini N., Kris M.G., Flehinger B.J., Gralla R.J., Bains M.S., Burt M.E., Heelan R., McCormack P.M., Pisters K.M.W., Rigas J.R., Rusch V.W., Ginsberg R.J. Preoperative chemotherapy for stage IIIA (N2) lung cancer: The Sloan-Kettering experience with 136 patients. Ann Thorac Surg. 55:1993;1365-1374.
9. Pisters KMW, Kris MG, Gralla RJ, Martini N. Preoperative chemotherapy in stage IIIA non-small cell lung cancer: an analysis of a trial of patients with clinically apparent mediastinal node involvement. In: Salmon SE, editor. Adjuvant Therapy of Cancer: VI. Philadelphia: W.B. Saunders Company, 1990:133-7.
10. Rosell R., Gomez-Condina J., Camps C., Maestre J., Padilla J., Canto A., Mate J.L., Li S., Roig J., Olazabal A., Canela M., Ariza A., Skacel Z., Morera J., Abad A. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non- small-cell lung cancer. N Engl J Med. 330:1994;153-158.
11. Roth J.A., Fossella F., Komaki R., Ryan M.B., Putnam J.B. Jr., Lee J.S., Dhingra H., DeCaro L., Chasen M., McGavran M., Atkinson E.N., Hong W.K. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst. 86:1994;673-680.
12. Skarin A., Jochelson M., Sheldon T., Malcolm A., Oliynky P., Hunt M., Frei I.E. Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small-cell lung cancer: long-term follow-up in 41 patients. J Surg Oncol. 40:1989;266-274.
13. Sridhar K.S., Thurer R., Kim Y., Fountzilas G., Davila E., Donnelly E., Charyuly K.K.N., Saldana M.J., Thompson T., Benedetto P., Raskin N., Beattie E.J. Multimodality treatment of non-small cell lung cancer: response to cisplatin, VP-16, and 5-FU chemotherapy and to surgery and radiation therapy. J Surg Oncol. 38:1988;193-195.
14. Strauss G.M., Herndon J.E., Sherman D.D., Mathisen D.J., Carey R.W., Choi N.C., Rege V.B., Modeas C., Green M.R. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a cancer and leukemia group B phase II study. J Clin Oncol. 10(8):1992;1237-1244.
15. Takita H., Regal A.M., Antkowiak J.G., Rao U.N.M., Botsoglou N.K., Lane W.W. Chemotherapy followed by lung resection in inoperable non-small cell lung carcinomas due to locally far-advanced disease. Cancer. 57:1986;630-635.
16. Vokes E.E., Bitran J.D., Hoffman P.C., Ferguson M.K., Weichselbaum R.R., Golomb H.M. Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. Chest. 96:1989;110-113.
17. Weiden P.L., Piantadosi S. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the lung cancer study group. J Natl Cancer Inst. 83(4):1991;266-273.